https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-25 / J Glob Oncol 2018 Sep;4:1-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-25 / J Glob Oncol 2018 Sep;4:1-42017-07-25 00:00:002017-07-25 00:00:00Retrospective Clinical Study of Advanced Pancreatic Cancer Treated With Chemotherapy and Abdominal Hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-19 / Int J Cancer 2017 11;141(9):1891-1900
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-19 / Int J Cancer 2017 11;141(9):1891-19002017-07-19 00:00:002021-11-15 20:03:02Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-15 / Cancer Immunol. Immunother. 2017 Oct;66(10):1249-1264
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-15 / Cancer Immunol. Immunother. 2017 Oct;66(10):1249-12642017-07-15 00:00:002019-02-15 09:23:07Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-04 / Oncotarget 2017 Jul;8(27):44593-44604
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-04 / Oncotarget 2017 Jul;8(27):44593-446042017-07-04 00:00:002019-02-15 09:18:16The effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-06-27 / Oncotarget 2017 Sep;8(40):67439-67456
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-06-27 / Oncotarget 2017 Sep;8(40):67439-674562017-06-27 00:00:002017-06-27 00:00:00Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-06-20 / Oncotarget 2017 Jun;8(25):41538-41548
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-06-20 / Oncotarget 2017 Jun;8(25):41538-415482017-06-20 00:00:002019-02-15 08:51:22A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-06-07 / Biomed Res Int 2017;2017:5618174
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-06-07 / Biomed Res Int 2017;2017:56181742017-06-07 00:00:002017-06-07 00:00:00Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-06-06 / Clin Transl Oncol 2017 Dec;19(12):1489-1497
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-06-06 / Clin Transl Oncol 2017 Dec;19(12):1489-14972017-06-06 00:00:002017-06-06 00:00:00Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-06-05 / J Clin Oncol 35, 2017 (suppl; abstr 3089)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-06-05 / J Clin Oncol 35, 2017 (suppl; abstr 3089)2017-06-05 12:09:062019-07-17 12:09:34Association of autologous AdHER2 dendritic cell vaccination with antitumor activity and number of circulating tumor cells.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-06-03 / Arch. Virol. 2017 Sep;162(9):2705-2713
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-06-03 / Arch. Virol. 2017 Sep;162(9):2705-27132017-06-03 00:00:002019-02-15 08:39:31Evaluation of the oncolytic potential of RB Mukteshwar vaccine strain of Newcastle disease virus (NDV) in a colon cancer cell line (SW-620)
